Comparing the effectiveness and costs of diabetes medications for older adults
Comparative and cost effectiveness of diabetes medications
This study looks at how well newer diabetes medications work for older adults, comparing them to traditional treatments to see if they offer better health benefits and if they're worth the extra cost.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Boston Health Care System NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10923800 on NIH RePORTER |
What this research studies
This research investigates the effectiveness and cost of various diabetes medications, particularly focusing on older adults aged 65 and over. It aims to understand how newer medications, like GLP1 and SGLT2 inhibitors, compare to traditional treatments in terms of benefits, risks, and overall costs. By analyzing real-world data, the study seeks to determine if these newer medications can lead to better health outcomes and whether they are worth the higher costs associated with them. The findings could help guide treatment decisions for older patients with diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who are managing diabetes and may be considering different medication options.
Not a fit: Patients under the age of 65 or those who do not have diabetes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more informed treatment choices for older adults with diabetes, potentially improving their health outcomes and reducing healthcare costs.
How similar studies have performed: Previous research has shown promising results in comparing diabetes medications, but this study aims to provide more specific insights for older adults, making it a valuable addition to existing knowledge.
Where this research is happening
Boston, United States
- VA Boston Health Care System — Boston, United States (Active)
Researchers
- Principal investigator: Conlin, Paul R — VA Boston Health Care System
- Study coordinator: Conlin, Paul R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.